Notably, extensive population-based studies have consistently reported lower plasma ApoE levels in individuals carrying one or two ε4 alleles, and have linked these reduced levels to an increased risk of dementia and mortality, independently of genotype [4, 31, 33–35]. Here, APOE is linked to dementia.